Navigation Links
Nektar Therapeutics Announces Second Quarter 2008 Results
Date:8/6/2008

quarter and first half of 2008 compared to a year ago is primarily the result of a loss of gross margin associated with Pfizer's termination of the Exubera collaboration and maintenance of Exubera manufacturing capacity through April 2008. The final spending and charges associated with the termination of the Exubera inhaled insulin program were paid and recorded in the second quarter of 2008.

"Over the past year, Nektar has made excellent progress in expanding and advancing our pipeline while at the same time maintaining financial discipline," said Nektar President and CEO Howard W. Robin. "In 2008, we will have seven proprietary programs in clinical development and an impressive preclinical pipeline of important, high-value therapeutics. We have executed on our strategy of building valuable proprietary programs without pursuing any dilutive financings."

Nektar will host a conference call today for analysts and investors at 2:00 p.m. Pacific time to discuss the company's second quarter performance. This conference call will be available via webcast and can be accessed through a link that is posted on the Investor Relations section of the Nektar website, http://www.nektar.com. The web broadcast of the conference call will be available for replay through August 20, 2008.

To access the conference call, follow these instructions:

Dial: (866) 831-5605 (U.S.); (617) 213-8851 (international)

Passcode: 33430853 (Howard Robin is the host)

Audio replay dial-in and passcode:

Dial: (888) 286-8010 (U.S.); (617) 801-6888 (international)

Passcode: 67859021

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
2. Nektar Therapeutics Announces First Quarter 2008 Results
3. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
4. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
5. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
7. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
8. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
9. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
10. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
11. InteKrin Therapeutics Announces $20 Million Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical ... Centers in order to offer his patients a new system of care utilizing laser ... , Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and ...
(Date:7/27/2015)... , ... July 28, 2015 , ... Combination Product GMP ... – 3:00 p.m. EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug ... of combination products things can get messy in a hurry. In a 46-page draft ...
(Date:7/27/2015)... ... July 28, 2015 , ... Recently, the Anderson ... medicine provider for the entire school district including Anderson County Middle School (ACMS) ... Rick Sallee, “Student safety and well-being are a top priority for us in ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women ... VIP Woman of the Year Circle. She is recognized with this prestigious distinction for ... NAPW is the nation’s leading networking organization exclusively for professional women. , “I’m pleased ...
(Date:7/27/2015)... Garden City, NY (PRWEB) , ... July 28, 2015 , ... ... as a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. ... 700,000 members and over 200 operating Local Chapters, NAPW is the nation’s leading networking ...
Breaking Medicine News(10 mins):Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 2Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2
... (USEPA) has awarded nearly $700,000 to Dionysios Dionysiou and ... , The USEPA awarded the grant of $698,689 ... understanding of how toxins produced by cyanobacteria (blue-green algae) ... a process used to disinfect drinking water. The research ...
... of teens who report solely positive benefits from not ... new study by scientists at the University of California, ... should give teens guidance in coping with both the ... negative experiences of refraining from them, the researchers say. ...
... Mass., Jan. 8 Haemonetics,Corporation (NYSE: HAE ) will announce its Q3FY08 ... conference call., Conference Call Dial-In Information ... 935-8754 (International) ID: 30405896 This ... the replay, please dial:, (800) 642-1687 ...
... Isolagen(TM), Inc. (Amex: ILE ),announced today that Nicholas ... of Isolagen, will present at the 26th Annual,JPMorgan Healthcare ... Time) / 11:00 a.m. (Eastern Time). The conference will ... Francisco, California., The presentation will be webcast live ...
... to be provided to select Red Cross Donor Centers and ... provided for people who give or attempt to give blood, ... Blood,Donor Month, Dunkin, Donuts will recognize American Red Cross Donors,Employees ... Beginning Thursday, January 17 through Thursday, January 31, all donors,at ...
... As 2008 begins, millions of Americans are having to dig deeper ... see a doctor. , The reason" Higher co-payments that took effect ... of health insurance by making employees and retirees pay more. ... co-pays should go down at least for some people taking ...
Cached Medicine News:Health News:EPA grant to UC engineering makes for a better environment 2Health News:EPA grant to UC engineering makes for a better environment 3Health News:EPA grant to UC engineering makes for a better environment 4Health News:EPA grant to UC engineering makes for a better environment 5Health News:Teens find the benefits of not having sex decline with age 2Health News:Teens find the benefits of not having sex decline with age 3Health News:Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference 2Health News:Dunkin' Donuts Celebrates the New Year by Supplying Goodies to Michigan's American Red Cross 2Health News:Study proves the co-pay connection in chronic disease 2Health News:Study proves the co-pay connection in chronic disease 3Health News:Study proves the co-pay connection in chronic disease 4
(Date:7/27/2015)... July 27, 2015  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Monday, ... Officer will lead the call. ... 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, including Replay ...
(Date:7/27/2015)... ALBANY, New York , July 27, 2015 ... Transparency Market Research "Bionics Market - Global Industry Analysis, Size, ... market was valued at USD 7.96 billion in 2014, growing ... account for USD 20.49 billion in 2021. The ... in the number of accidents, which is leading to paralysis ...
(Date:7/27/2015)... DUBLIN , July 20, 2015 Research ... of the "Medical Device Regulation in Asia/Pacific Markets ... Now that the European Medical Device market is well ... . China , together with ... are in the process of implementing, their own medical ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... GPP Plays Critical Role in Moving HIV Prevention Research Agenda Forward ... VIENNA , July 23 ... Guidelines for Biomedical HIV Prevention Trials were released yesterday at the International ... aim to provide trial funders, sponsors, and implementers with systematic guidance on how ...
... July 22 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... received a letter from the Nasdaq Stock Market stating that the ... $1.00 per share for 30 consecutive business days and ... bid price requirement for continued listing set forth in Marketplace Rule ...
Cached Medicine Technology:New Edition of Guidelines for Involving Communities in HIV Prevention Research Released at International AIDS Conference 2Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price 2Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price 3
... kit is an enzymeimmunoassay for the quantitation ... in serum or plasma. Calibrators, controls and ... D. The diluted samples are incubated in ... highly specific sheep 25-OH D antibody for ...
... responsible for the control of glucose metabolism. ... islets of Langerhans as the precursor, proinsulin, which ... Both are secreted in equimolar amounts into the ... comprised of two polypeptide chains, the A-chain and ...
... Angiotensin Converting Enzyme (ACE) is an integral ... the generation of Angiotensin II as well ... many different cell types, ACE is primarily ... only an important diagnostic parameter for sarcoidosis ...
... (RBP) is small (21kD) transport protein for ... in blood but loses its affinity for,prealbumin ... the target cells. The free,RBP molecule is ... catabolized in the,renal tubules after resorption by ...
Medicine Products: